Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Essent Group $500 million senior notes offering
The 6.25% investment-grade senior notes are due 2029
Recursion Pharmaceuticals $230 million follow-on offering
The shares are listed on the Nasdaq Global Select Market
InflaRx $75 million at-the-market offering
The shares are listed on the Nasdaq Global Market
XP $500 million senior notes offering and concurrent tender offer
We advised XP on its Rule 144A / Regulation S unsecured notes offering and concurrent tender offer
Peru $4.07 billion sovereign bond issuance and offers to tender and exchange
We advised Peru on the transactions
CCC Intelligent Solutions Holdings $339 million secondary offering
The shares are listed on the Nasdaq Global Select Market
Millicom tender offer by Atlas Luxco
We are advising Millicom’s independent committee on the tender offer
Hertz $1 billion financing
We advised Hertz on the transactions
Sealed Air $400 million senior notes offering and concurrent tender offer
The new high-yield notes are due 2032
Pepkor Holdings ZAR 9 billion secondary offering
The accelerated bookbuild transaction represented approximately 13.6% of Pepkor’s issued share capital